ELASTY Grand® Dermal Filler
High-Density Cross-Linked Hyaluronic Acid (24mg/ml) for Deep Tissue Augmentation · 98% Patient Satisfaction Rate in Clinical Trials
Advanced HESE Technology & CE Certification
ELASTY Grand utilizes High Elasticity Stabilization Engineering (HESE®) to create hyaluronic acid with 85% cross-linking density. The optimized G’-value of 350Pa provides exceptional lift capacity while maintaining natural viscoelasticity. Manufactured under ISO 13485 standards with 0.22μm terminal filtration, containing 24mg/ml HA concentration and zero animal-derived ingredients. Particle size optimized at 450μm±50 for precise deep dermal placement.
Clinical Performance
Structural Longevity
18-24 month persistence in nasolabial folds (Multi-center study, n=1,200)
Lifting Capacity
Supports 5.2mm vertical lift in cheek augmentation procedures
Safety Profile
0.12% adverse reaction rate in post-market surveillance (N=15,000)
Hydration Efficacy
Increases skin moisture retention by 63% at 6-month follow-up
Technical Specifications
- Concentration: Hyaluronic Acid 24mg/ml
- Packaging: 2 × 1ml sterile syringes
- Cross-linking: BDDE 1.5ppm residual
- pH Value: 7.2±0.3
- Preservation: Room temperature (1-30°C)
- Shelf Life: 24 months unopened
Injection Protocol
- Needle: 27G 0.5″ cannula recommended
- Depth: Supraperiosteal layer placement
- Max Volume: 2ml per treatment area
- Technique: Linear threading with retrograde injection
- Anesthesia: Topical ice application preferred
Aesthetic Applications
Midface Augmentation
Cheekbone enhancement: Deposit 0.5-1ml per side in supraperiosteal plane using 25mm cannula. Provides natural 3D projection lasting 18-24 months.
Lip Contouring
Vermillion border definition: 0.3-0.5ml per lip quadrant via microbolus technique. Maintains 89% volume retention at 12 months.
Nasolabial Correction
Deep fold treatment: 0.8-1.2ml per fold using fanning technique. Shows 72% improvement on Wrinkle Severity Scale.
Important Clinical Notice
Notice: Individual results may vary based on tissue characteristics and injection technique. Must be administered by board-certified dermatologists or plastic surgeons. Contraindications include: active skin infections, history of severe allergic reactions, and bleeding disorders.
Post-treatment monitoring required for first 72 hours. Avoid facial manipulations/massage for 14 days. Report immediately if vascular compromise suspected. Not recommended for pregnant/lactating women.
Reviews
There are no reviews yet.